Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Assessing SARS-CoV-2-specific T-cell reactivity in late convalescents and vaccinees: Comparison and combination of QuantiFERON and activation-induced marker assays, and relation with antibody status.
Gatti A, Zizzo G, De Paschale M, Tamburello A, Castelnovo L, Faggioli PM, Clerici P, Brando B, Mazzone A. Gatti A, et al. Among authors: castelnovo l. PLoS One. 2023 May 23;18(5):e0285728. doi: 10.1371/journal.pone.0285728. eCollection 2023. PLoS One. 2023. PMID: 37220145 Free PMC article.
Fibrosis biomarkers in isolated Raynaud's phenomenon: too little, too soon?
Ingegnoli F, Gualtierotti R, Schioppo T, Orenti A, Boracchi P, Lubatti C, Mastaglio C, Galbiati V, Murgo A, Zeni S, Grossi C, Borghi O, Rosenberg W, Castelnovo L, Meroni Pier L. Ingegnoli F, et al. Among authors: castelnovo l. Ann Rheum Dis. 2014 May;73(5):940-1. doi: 10.1136/annrheumdis-2013-204009. Epub 2013 Dec 16. Ann Rheum Dis. 2014. PMID: 24344159 No abstract available.
Recommendations for managing the manifestations of severe and life-threatening mixed cryoglobulinemia syndrome.
Galli M, Monti G, Marson P, Scaini P, Pietrogrande M, Candela M, Castelnovo L, Faggioli P, Novati P, Zani R, Mascia MT, Saccardo F, Mazzaro C, Sarzi-Puttini P, Sebastiani M, Quartuccio L, De Vita S. Galli M, et al. Among authors: castelnovo l. Autoimmun Rev. 2019 Aug;18(8):778-785. doi: 10.1016/j.autrev.2019.06.008. Epub 2019 Jun 8. Autoimmun Rev. 2019. PMID: 31181326
Symmetric cutaneous vasculitis in COVID-19 pneumonia.
Castelnovo L, Capelli F, Tamburello A, Faggioli PM, Mazzone A. Castelnovo L, et al. J Eur Acad Dermatol Venereol. 2020 Aug;34(8):e362-e363. doi: 10.1111/jdv.16589. Epub 2020 May 27. J Eur Acad Dermatol Venereol. 2020. PMID: 32378747 Free PMC article. No abstract available.
COVID-19 in rheumatic diseases in Italy: first results from the Italian registry of the Italian Society for Rheumatology (CONTROL-19).
Scirè CA, Carrara G, Zanetti A, Landolfi G, Chighizola C, Alunno A, Andreoli L, Caporali R, Gerli R, Sebastiani GD, Valesini G, Sinigaglia L; Italian Registry of the Italian Society for Rheumatology (CONTROL-19). Scirè CA, et al. Clin Exp Rheumatol. 2020 Jul-Aug;38(4):748-753. Epub 2020 Jul 28. Clin Exp Rheumatol. 2020. PMID: 32723435 Free article.
Prevalence of COVID infections in a population of rheumatic patients from Lombardy and Marche treated with biological drugs or small molecules: A multicentre retrospective study.
Sarzi-Puttini P, Marotto D, Caporali R, Montecucco CM, Favalli EG, Franceschini F, Fredi M, Balduzzi S, Bazzani C, Bongiovanni S, Giorgi V, Batticciotto A, Cappelli A, Balzarini P, Dagna L, Sartorelli S, Ravagnani V, Tamanini S, Farah S, Faggioli P, Castelnovo L, Lurati AM, Galli M, Salaffi F. Sarzi-Puttini P, et al. Among authors: castelnovo l. J Autoimmun. 2021 Jan;116:102545. doi: 10.1016/j.jaut.2020.102545. Epub 2020 Sep 22. J Autoimmun. 2021. PMID: 32972804 Free PMC article.
Anti-IL6 treatment of serious COVID-19 disease: A monocentric retrospective experience.
Castelnovo L, Tamburello A, Lurati A, Zaccara E, Marrazza MG, Olivetti M, Mumoli N, Mastroiacovo D, Colombo D, Ricchiuti E, Vigano' P, Paola F, Mazzone A. Castelnovo L, et al. Medicine (Baltimore). 2021 Jan 8;100(1):e23582. doi: 10.1097/MD.0000000000023582. Medicine (Baltimore). 2021. PMID: 33429732 Free PMC article.
Use of rituximab in a multicentre cohort of patients with rheumatic diseases during the outbreak of novel SARS-COV-2 infection.
Batticciotto A, Marotto D, Giorgi V, Balzarini P, Favalli EG, Balduzzi S, Fredi M, Bazzani C, Sartorelli S, Ravagnani V, Tamanini S, Castelnovo L, Lurati AM, Farah S, Bongiovanni S, Caporali R, Dagna L, Faggioli P, Franceschini F, Montecucco CM, Salaffi F, Galli M, Cappelli A, Sarzi-Puttini P. Batticciotto A, et al. Among authors: castelnovo l. Clin Exp Rheumatol. 2021 May-Jun;39(3):695. doi: 10.55563/clinexprheumatol/6z3ong. Epub 2021 Feb 26. Clin Exp Rheumatol. 2021. PMID: 33635224 Free article. No abstract available.
Ferritin as prognostic marker in COVID-19: the FerVid study.
Para O, Caruso L, Pestelli G, Tangianu F, Carrara D, Maddaluni L, Tamburello A, Castelnovo L, Fedi G, Guidi S, Pestelli C, Pennella B, Ciarambino T, Nozzoli C, Dentali F. Para O, et al. Among authors: castelnovo l. Postgrad Med. 2022 Jan;134(1):58-63. doi: 10.1080/00325481.2021.1990091. Epub 2021 Oct 17. Postgrad Med. 2022. PMID: 34613875 Free PMC article.
47 results